Vigil Neuroscience (VIGL) Competitors $1.62 +0.02 (+0.94%) As of 12:02 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VIGL vs. HRTX, RGNX, VERV, TECX, ORKA, MREO, BNTC, AURA, CYRX, and RNACShould you be buying Vigil Neuroscience stock or one of its competitors? The main competitors of Vigil Neuroscience include Heron Therapeutics (HRTX), REGENXBIO (RGNX), Verve Therapeutics (VERV), Tectonic Therapeutic (TECX), Oruka Therapeutics (ORKA), Mereo BioPharma Group (MREO), Benitec Biopharma (BNTC), Aura Biosciences (AURA), Cryoport (CYRX), and Cartesian Therapeutics (RNAC). These companies are all part of the "pharmaceutical products" industry. Vigil Neuroscience vs. Heron Therapeutics REGENXBIO Verve Therapeutics Tectonic Therapeutic Oruka Therapeutics Mereo BioPharma Group Benitec Biopharma Aura Biosciences Cryoport Cartesian Therapeutics Vigil Neuroscience (NASDAQ:VIGL) and Heron Therapeutics (NASDAQ:HRTX) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, valuation, institutional ownership, media sentiment, community ranking and earnings. Which has more volatility and risk, VIGL or HRTX? Vigil Neuroscience has a beta of 1.94, meaning that its stock price is 94% more volatile than the S&P 500. Comparatively, Heron Therapeutics has a beta of 1.39, meaning that its stock price is 39% more volatile than the S&P 500. Does the media favor VIGL or HRTX? In the previous week, Heron Therapeutics had 4 more articles in the media than Vigil Neuroscience. MarketBeat recorded 5 mentions for Heron Therapeutics and 1 mentions for Vigil Neuroscience. Vigil Neuroscience's average media sentiment score of 1.89 beat Heron Therapeutics' score of 1.00 indicating that Vigil Neuroscience is being referred to more favorably in the media. Company Overall Sentiment Vigil Neuroscience Very Positive Heron Therapeutics Positive Which has stronger earnings and valuation, VIGL or HRTX? Vigil Neuroscience has higher earnings, but lower revenue than Heron Therapeutics. Heron Therapeutics is trading at a lower price-to-earnings ratio than Vigil Neuroscience, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVigil NeuroscienceN/AN/A-$82.64M-$2.06-0.78Heron Therapeutics$144.29M2.05-$110.56M-$0.09-21.57 Is VIGL or HRTX more profitable? Vigil Neuroscience has a net margin of 0.00% compared to Heron Therapeutics' net margin of -20.31%. Heron Therapeutics' return on equity of 0.00% beat Vigil Neuroscience's return on equity.Company Net Margins Return on Equity Return on Assets Vigil NeuroscienceN/A -83.89% -65.34% Heron Therapeutics -20.31%N/A -12.72% Do institutionals and insiders hold more shares of VIGL or HRTX? 83.6% of Vigil Neuroscience shares are held by institutional investors. Comparatively, 80.0% of Heron Therapeutics shares are held by institutional investors. 18.0% of Vigil Neuroscience shares are held by company insiders. Comparatively, 5.8% of Heron Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Do analysts rate VIGL or HRTX? Vigil Neuroscience currently has a consensus target price of $16.25, indicating a potential upside of 906.19%. Heron Therapeutics has a consensus target price of $5.67, indicating a potential upside of 191.95%. Given Vigil Neuroscience's higher probable upside, equities analysts clearly believe Vigil Neuroscience is more favorable than Heron Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vigil Neuroscience 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Heron Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community prefer VIGL or HRTX? Heron Therapeutics received 635 more outperform votes than Vigil Neuroscience when rated by MarketBeat users. However, 84.62% of users gave Vigil Neuroscience an outperform vote while only 68.87% of users gave Heron Therapeutics an outperform vote. CompanyUnderperformOutperformVigil NeuroscienceOutperform Votes3384.62% Underperform Votes615.38%Heron TherapeuticsOutperform Votes66868.87% Underperform Votes30231.13% SummaryVigil Neuroscience beats Heron Therapeutics on 10 of the 16 factors compared between the two stocks. Remove Ads Get Vigil Neuroscience News Delivered to You Automatically Sign up to receive the latest news and ratings for VIGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VIGL vs. The Competition Export to ExcelMetricVigil NeuroscienceBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$79.33M$2.89B$5.34B$7.60BDividend YieldN/A1.91%5.11%4.33%P/E Ratio-0.7830.6721.7617.83Price / SalesN/A437.46378.0693.28Price / CashN/A168.6838.1534.64Price / Book0.503.476.414.00Net Income-$82.64M-$72.06M$3.20B$247.23M7 Day Performance15.36%8.70%6.59%7.42%1 Month Performance-20.05%-17.38%-8.57%-6.15%1 Year Performance-48.89%-29.70%10.11%-0.03% Vigil Neuroscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VIGLVigil Neuroscience3.3722 of 5 stars$1.62+0.9%$16.25+906.2%-50.3%$79.33MN/A-0.7840Positive NewsGap UpHRTXHeron Therapeutics3.4789 of 5 stars$1.96-6.7%$5.67+189.1%-33.7%$298.57M$144.29M-10.89300News CoveragePositive NewsRGNXREGENXBIO4.7132 of 5 stars$5.93-5.7%$32.78+452.7%-65.0%$297.01M$83.33M-1.18370Positive NewsGap DownVERVVerve Therapeutics2.9429 of 5 stars$3.34-7.7%$20.67+518.8%-45.8%$296.58M$32.33M-1.36110Analyst ForecastOptions VolumeNews CoverageGap UpHigh Trading VolumeTECXTectonic Therapeutic2.807 of 5 stars$15.53-0.6%$77.75+400.6%N/A$289.84MN/A-2.64120Short Interest ↑Positive NewsGap DownORKAOruka Therapeutics2.9139 of 5 stars$7.62-2.7%$39.86+423.1%N/A$285.30MN/A-1.22N/ANews CoveragePositive NewsHigh Trading VolumeMREOMereo BioPharma Group2.1087 of 5 stars$1.83-8.0%$7.71+321.5%-30.1%$283.92M$1M-30.5040Gap DownHigh Trading VolumeBNTCBenitec Biopharma2.1708 of 5 stars$12.02-2.4%$24.43+103.2%+141.3%$281.88M$80,000.00-7.9620Short Interest ↑AURAAura Biosciences1.9679 of 5 stars$5.52+1.7%$22.75+312.1%-27.7%$277.24MN/A-3.1950Short Interest ↑CYRXCryoport2.6669 of 5 stars$5.49+2.6%$11.83+115.5%-67.6%$274.01M$228.39M-1.621,020Gap DownRNACCartesian Therapeutics1.8541 of 5 stars$10.11+1.1%$42.14+316.8%-33.0%$261.92M$38.91M-0.1964 Remove Ads Related Companies and Tools Related Companies HRTX Competitors RGNX Competitors VERV Competitors TECX Competitors ORKA Competitors MREO Competitors BNTC Competitors AURA Competitors CYRX Competitors RNAC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VIGL) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vigil Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vigil Neuroscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VIGL Stock Free VIGL Stock Alerts